FACT Reaffirms Commitment to Strategic Imperatives, Supported by Our Core Values

Posted in :: 2026 July :: Tuesday, June 30th, 2026

By Kara Wacker, External Relations and Strategy

The year of FACT’s 30th anniversary was the perfect time for the headquarters team to pause its rapid pace of work to celebrate and reflect in Music City. FACT President Navneet Majhail, the Board of Directors, and senior leaders hosted the team in Nashville to provide professional training, reaffirm commitment to our strategic imperatives, and celebrate our accomplishments.

A major focus was rallying around four strategic imperatives established by the Board last year. These imperatives are guided by our dedication to move FACT Forward into the future of cellular therapy:

  1. Expand Access: Help expand eligible patient access to safe and quality-based CAR T therapies throughout America’s communities.

    Overarching Objective: Deliver highly valued, forward-looking services and resources to community oncologists pursuing FACT accreditation as an assurance of quality and safety.

    Dedication from our Community CAR T Working Group, Standards Committee, FACT Board, expert reviewers, and headquarters staff resulted in the swift publication of fit-for-purpose Community IEC Standards and the implementation of an associated accreditation program. We continue to support inaugural community-based programs that have applied and will soon announce an initiative to help a “first wave” accelerate their path to accreditation.

  2. Standards Forward: Critically examine FACT Standards to maximize relevance, minimize redundancy, enhance accessibility, and improve development efficiency.

    Overarching Objective: Expert peers work efficiently to produce timely, principle-based Standards that are clear and meaningful to all stakeholders.

    Our Standards are the foundation of nearly all FACT activities. As the cellular therapy field evolves, so must our approach to developing and reviewing requirements. The Board has charged the headquarters team with building workflows that ensure Standards remain peer-driven, consensus-based, and focused on safety and quality.

  3. Accreditation Forward: Evaluate and improve accreditation processes to enhance efficiency and user experience for applicants, inspectors, and staff.

    Overarching Objective: Create streamlined workflows supported by user-friendly technology, maximizing efficiency and satisfaction across all participants.

    FACT’s accreditation process is intentionally rigorous to protect patient safety and ensure quality care. At the same time, opportunities exist to reduce operational burden and improve turnaround times. Our goal is to make the process as efficient and user-friendly as possible without compromising standards.

  4. Governance & Practices: Ensure FACT’s bylaws and organizational policies remain relevant, transparent, and effectively implemented.

    Overarching Objective: Maintain a strategically oriented, inclusive, and transparent organizational structure guided by evolving, principle-based policies.

    Organizational evolution is essential as cellular therapy advances and new stakeholders emerge. A task force of FACT Directors is currently proposing updates to our bylaws to support agility and responsiveness moving forward.

Much of these discussions took place in the context of our newly defined core values. At FACT, our work is guided by a shared commitment to advancing the quality, safety, and future of cellular therapy. These values define how we collaborate, serve stakeholders, and uphold our mission.

FACT Core Values

These values are not only aspirational but already embedded in FACT’s culture. They align directly with our mission and position FACT for continued growth in cellular therapy. As we advance our strategic imperatives, we do so with integrity, collaboration, adaptability, respect, and excellence.